Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Mesenchymal Stem Cells for ACLF
NCT06884904Phase 3Not yet recruiting
- Sponsor
- National Engineering Center of Cell Products
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in acute-on-chronic liver failure (ACLF), sponsored by National Engineering Center of Cell Products. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT06884904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06884904.